Carlos Portera-Cailliau

Dr. Keith Vossel is the Michael M. Minchin, Jr., President, J.D. French Alzheimer’s Foundation Endowed Chair and Professor of Neurology in the David Geffen School of Medicine at UCLA. He leads a comprehensive Center incorporating outreach and engagement to diverse communities, electronic health records, social determinants of health, neuroimaging, neurophysiology, genetics, preclinical and clinical trials, and clinical care to develop new therapies for Alzheimer’s disease and related dementias and achieve equity in recognition and care of dementia. 

Dr. Vossel received a master’s degree in biomedical engineering and medical degree with highest honors from the University of Tennessee. He completed neurology residency at Harvard Medical School/Massachusetts General Hospital and Brigham and Women's Hospital, where he served as a chief resident. Dr. Vossel completed fellowship training in behavioral neurology and dementia research at the University of California, San Francisco and Gladstone Institutes. 

Dr. Vossel investigates Alzheimer's disease and related dementias with a focus on brain rhythm abnormalities and translational therapies. Key discoveries include the presence of silent epileptic activity, occurring during sleep and accelerating cognitive decline in Alzheimer’s disease, effects of amyloid-β and tau deposition on brain rhythms and related cognitive impairments in Alzheimer’s disease, and novel pathological functions of tau in Alzheimer’s disease and dementia with Lewy bodies. Dr. Vossel led a phase 2a clinical trial showing that low doses of an antiseizure drug can improve memory and problem solving in patients with Alzheimer’s disease and detectable epileptic activity. Dr. Vossel is broadening these studies in Greater Los Angeles and incorporating them into the expanded activities of the Alzheimer’s Disease Research Center in the UCLA Easton Center.